Joimax has obtained full product registration for its endoscopic minimally invasive spinal surgery platform from the Thai Food & Drug Administration.
This adds to its approvals in South Korea, China, Singapore, Indonesia, Hong Kong and Vietnam. For Malaysia, Taiwan and Japan, the certification for the product range is expected in 2017.
